Z-VEID-FMK: Caspase-6 Inhibition in Cell Assays
2026-08-10
This scenario-driven guide explains how Z-VEID-FMK, SKU A1923, can help researchers separate caspase-6-dependent apoptosis from nonspecific loss of viability. It covers solvent selection, protocol parameters, interpretation of antiviral findings, and practical criteria for choosing a reliable caspase-6 inhibitor.
O6-Benzylguanine: A Mechanism-First MGMT Workflow
2026-08-09
O6-Benzylguanine is a potent MGMT inhibitor for dissecting DNA repair inhibition and sensitization to alkylating agents. This mechanism-first guide connects direct enzyme inactivation with transcriptional MGMT regulation in glioma, improving assay design and interpretation.
BHQ: Interpreting SERCA Perturbation
2026-08-08
Explore how 2,5-di-tert-butylbenzene-1,4-diol (BHQ) can function as a temporal probe of SERCA-dependent calcium biology. This article connects assay design, ER stress, vascular physiology, and hematopoietic stem cell mobilization while emphasizing causal interpretation and experimental limits.
Relative Versus Fractional Viability in Cancer Drug Testing
2026-08-07
Hannah R. Schwartz’s dissertation shows why relative viability and fractional viability should not be treated as interchangeable measures of anticancer drug response. Its central contribution is a framework for separating growth inhibition from cell killing, helping researchers interpret response kinetics and design more informative in vitro experiments.
Leupeptin Hemisulfate Salt: Next-Gen Translational Strategy
2026-08-07
This article explores how Leupeptin hemisulfate salt is redefining protease activity regulation in translational research, integrating mechanistic insights, rigorous protocol guidance, and a forward-looking perspective on its impact in protein degradation and viral replication studies. Drawing on recent advances in metabolic-epigenetic crosstalk and competitive landscape analysis, we challenge conventional paradigms and offer actionable strategies for experimental design.
Plasma Dilution Rejuvenates Aged Mouse Brain Beyond Senolyti
2026-08-06
The referenced study demonstrates that plasma dilution, rather than young blood factors or senolytics alone, robustly improves cognition and reduces neuroinflammation in aged mice. This work redefines the mechanisms of systemic rejuvenation, showing that resetting the signaling milieu by neutral blood exchange (NBE) is more effective for brain health than Bcl-2 family inhibition.
Valemetostat Monotherapy in Relapsed/Refractory NHL: Phase 1
2026-08-06
This phase 1 clinical study evaluated valemetostat, a dual EZH2/EZH1 inhibitor, as monotherapy in patients with relapsed or refractory non-Hodgkin lymphoma. Results demonstrated a favorable safety profile and promising antitumor activity, establishing a recommended dose for further studies and highlighting new directions for targeted epigenetic therapy.
PBS Liposomes: Precision Controls for Macrophage Depletion S
2026-08-05
This thought-leadership article explores the critical mechanistic and translational foundations underpinning the use of PBS Liposomes in macrophage depletion assays. By integrating recent advances in ion channel biology, especially the structural modulation of TRPM3 in pain and neurodevelopmental disorders, we provide translational researchers with actionable strategies to optimize experimental design, interpret immunological outcomes, and ensure reproducibility. We highlight how APExBIO's PBS Liposomes serve as an indispensable control, contrast current approaches, and illuminate the future landscape of immunological research at the interface of molecular neuroscience.
Berberine Hydrochloride: Applied Protocols in Metabolic Rese
2026-08-05
Berberine hydrochloride from APExBIO empowers high-impact metabolic and cardiovascular research through precise AMPK activation and LDL receptor modulation. This guide translates recent bench discoveries and advanced troubleshooting into actionable workflows, maximizing reproducibility in disease modeling.
Angiotensin Peptides Enhance SARS-CoV-2 Spike–AXL Binding
2026-08-04
Oliveira et al. (2025) uncovered that naturally occurring angiotensin peptides, including N-terminally truncated fragments, can significantly enhance the binding of the SARS-CoV-2 spike protein to its receptors, especially AXL. This finding reveals a novel interface between cardiovascular peptide signaling and viral entry mechanisms, with implications for both COVID-19 pathogenesis and the modeling of renin–angiotensin pathways.
Rocilinostat (ACY-1215): Optimizing HDAC6 Inhibition Workflo
2026-08-04
Rocilinostat (ACY-1215) delivers unmatched selectivity for HDAC6, enabling reproducible, high-fidelity assays in both cancer and neurodevelopmental research. This guide translates recent mechanistic advances and reference-model insights into actionable protocols, troubleshooting strategies, and comparative advantages for translational scientists.
DOT1L Inhibition Attenuates Renal Fibrosis via H3K79 Methyla
2026-08-03
This study demonstrates that DOT1L inhibition, using EPZ5676, significantly reduces renal fibrosis by suppressing fibroblast activation and epithelial-mesenchymal transition (EMT) in a murine model. The findings highlight the role of H3K79 methylation in fibrotic kidney disease and suggest a new epigenetic target for chronic kidney disease research.
Carfilzomib (PR-171): Advancing Proteasome Inhibition in ESC
2026-08-03
This article explores the mechanistic and translational frontiers of Carfilzomib (PR-171) as a next-generation proteasome inhibitor in esophageal squamous cell carcinoma (ESCC) research. Anchored by recent evidence on its synergy with Iodine-125 seed radiation, we provide protocol insights, biological rationales, and strategic guidance for translational researchers aiming to overcome radioresistance and enable multi-modal cell death in cancer models.
EDTA-Free Protease Inhibition: Advancing Translational Prote
2026-08-02
This article explores the mechanistic and strategic imperatives for using EDTA-free protease inhibitor cocktails in translational research. By integrating insights from cutting-edge cancer metabolism studies and current best practices in protein extraction, it offers actionable guidance for researchers navigating the challenges of protein integrity preservation, particularly in workflows sensitive to post-translational modifications. Special attention is given to the unique role of APExBIO’s Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO) in enabling high-fidelity biochemical and molecular analyses, bridging the gap between discovery and clinical translation.
Imipramine in Research: Tricyclic Antidepressant Workflows D
2026-08-01
Imipramine, renowned for its antidepressant action, is powering advanced research in autophagy, apoptosis, and neuroprotection. This guide details bench-proven workflows, troubleshooting, and the translational edge offered by Imipramine in cancer and neuroscience studies.
460 records 9/31 page Previous Next First page 上5页 678910 下5页 Last page